JP2024533153A5 - - Google Patents
Info
- Publication number
- JP2024533153A5 JP2024533153A5 JP2024513893A JP2024513893A JP2024533153A5 JP 2024533153 A5 JP2024533153 A5 JP 2024533153A5 JP 2024513893 A JP2024513893 A JP 2024513893A JP 2024513893 A JP2024513893 A JP 2024513893A JP 2024533153 A5 JP2024533153 A5 JP 2024533153A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21194879.9 | 2021-09-03 | ||
| EP21194879 | 2021-09-03 | ||
| EP22160234 | 2022-03-04 | ||
| EP22160234.5 | 2022-03-04 | ||
| PCT/EP2022/074420 WO2023031380A1 (en) | 2021-09-03 | 2022-09-02 | Dosage regime |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024533153A JP2024533153A (ja) | 2024-09-12 |
| JPWO2023031380A5 JPWO2023031380A5 (https=) | 2024-10-09 |
| JP2024533153A5 true JP2024533153A5 (https=) | 2024-10-09 |
Family
ID=84272918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513893A Pending JP2024533153A (ja) | 2021-09-03 | 2022-09-02 | 投薬レジーム |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250073311A1 (https=) |
| EP (1) | EP4392054A1 (https=) |
| JP (1) | JP2024533153A (https=) |
| KR (1) | KR20240058121A (https=) |
| AU (1) | AU2022339044A1 (https=) |
| CA (1) | CA3228429A1 (https=) |
| CL (1) | CL2024000647A1 (https=) |
| IL (1) | IL311166A (https=) |
| MX (1) | MX2024002600A (https=) |
| TW (1) | TW202315882A (https=) |
| WO (1) | WO2023031380A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025248124A1 (en) * | 2024-05-31 | 2025-12-04 | Zealand Pharma A/S | Dapiglutide for use in treating a sub-group of subjects |
| WO2026052859A1 (en) | 2024-09-09 | 2026-03-12 | Zealand Pharma A/S | Treatment with dapiglutide |
| WO2026052861A1 (en) | 2024-09-09 | 2026-03-12 | Zealand Pharma A/S | Treatment with dapiglutide |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL128332A0 (en) | 1996-08-30 | 2000-01-31 | Novo Nordisk As | GLP-1 derivatives |
| CZ295838B6 (cs) | 1996-09-09 | 2005-11-16 | Zealand Pharma A/S | Způsob výroby peptidů |
| US6451987B1 (en) | 1999-03-15 | 2002-09-17 | Novo Nordisk A/S | Ion exchange chromatography of proteins and peptides |
| EP1956000B1 (en) | 1999-03-17 | 2016-10-05 | Novo Nordisk A/S | Acylating agents useful for acylating peptides |
| AU2017371516C1 (en) | 2016-12-09 | 2021-09-02 | Zealand Pharma A/S | Acylated GLP-1/GLP-2 dual agonists |
| WO2018104558A1 (en) * | 2016-12-09 | 2018-06-14 | Zealand Pharma A/S | Acylated glp-1/glp-2 dual agonists |
| JP2020500890A (ja) * | 2016-12-09 | 2020-01-16 | ジーランド・ファーマ・ア／エス | Ｇｌｐ−１／ｇｌｐ−２二重アゴニスト |
| BR112021020941A2 (pt) | 2019-06-14 | 2021-12-21 | Zealand Pharma As | Composição farmacêutica parenteral isotônica, método para melhoria da estabilidade química da dita composição e uso de manitol |
| EP4126003A1 (en) * | 2020-03-30 | 2023-02-08 | Zealand Pharma A/S | Glp-1/glp-2 dual agonists |
| TW202241491A (zh) * | 2020-12-16 | 2022-11-01 | 丹麥商西蘭製藥公司 | Ｇｌｐ－１／ｇｌｐ－２雙重促效劑之醫藥組合物 |
| JP7809117B2 (ja) * | 2020-12-16 | 2026-01-30 | ジーランド ファーマ エー／エス | Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物 |
| TW202241492A (zh) * | 2020-12-16 | 2022-11-01 | 丹麥商西蘭製藥公司 | Ｇｌｐ－１／ｇｌｐ－２雙重促效劑之醫藥組合物 |
-
2022
- 2022-09-02 AU AU2022339044A patent/AU2022339044A1/en active Pending
- 2022-09-02 IL IL311166A patent/IL311166A/en unknown
- 2022-09-02 EP EP22805777.4A patent/EP4392054A1/en active Pending
- 2022-09-02 JP JP2024513893A patent/JP2024533153A/ja active Pending
- 2022-09-02 US US18/688,026 patent/US20250073311A1/en active Pending
- 2022-09-02 CA CA3228429A patent/CA3228429A1/en active Pending
- 2022-09-02 WO PCT/EP2022/074420 patent/WO2023031380A1/en not_active Ceased
- 2022-09-02 TW TW111133296A patent/TW202315882A/zh unknown
- 2022-09-02 MX MX2024002600A patent/MX2024002600A/es unknown
- 2022-09-02 KR KR1020247010163A patent/KR20240058121A/ko active Pending
-
2024
- 2024-03-01 CL CL2024000647A patent/CL2024000647A1/es unknown